Abstract
Sa1757 - Filgotinib Decreases Systemic and Mucosal Markers of Inflammation that are Associated with Endoscopic Improvement in Moderatly to Severely Active Crohn's Disease Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have